October 23 ,2008 - Elder Pharmaceuticals is buying out three small Bulgarian pharma companies through its wholly-owned subsidiary Elder-Biomeda in a share swap deal. The three companies have collective sales of around e8-10 million. All the three companies are sister concerns of Biomeda. In August, Elder enter

Read More >>

October 3 ,2008 - MUMBAI: Elder Pharmaceuticals (EPL) has scaled up its stake in its Nepalese JV by 9% to 49% for around Rs 60 crore. The Rs 550-crore pharma company has set up a 40:60 JV with Universal group of Kathmandu in 2006. “We plan to hike to our stake in the JV to 51% and make it our subsidiary. We have also

Read More >>

September 22 ,2008 - Elder Pharmaceuticals Ltd has been selected for the Lalit Doshi Memorial Award as the best SICOM assisted unit for the year 2007-08. The award is jointly given by Lalit Doshi Memorial Foundation and SICOM Limited, every year. This award was instituted thirteen years ago, in the memory of Late Shri L

Read More >>

July 31 ,2008 - The Mumbai-based Rs 500-crore Elder Pharmaceuticals today announced its unaudited financial results for the first quarter ended 30 June 2008. Review of quarterly financial performance: Elder Pharmaceuticals has reported a robust quarter-on-quarter revenue expansion with total income increase of 2

Read More >>

July 31 ,2008 - MUMBAI, July 31 (Reuters) - Elder Pharmaceuticals Ltd (ELDP.BO: Quote, Profile, Research) expects a minimum 20 percent rise in 2008/09 net profit, aided by new product launches, an official said Thursday after the firm posted a 16 percent rise in first-quarter profit. For the year to March 2009, Mu

Read More >>

July 22 ,2008 - MUMBAI: The California-based bio-pharmaceutical company, Cymbiotics, has signed an in-licensing deal with Elder Pharmaceuticals to market six of its patented products in India. As per the agreement, Elder will market Cymbiotics products in pain management, diabetics, dermatology, besides OTC prod

Read More >>

February 21 ,2008 - The Mumbai based Elder Pharmaceuticals has launched a new product, Phytomega, a unique combination of Omega-3 fatty acids and Phytosterols in the domestic market. It will help to reduce heart disease risks. Phytomega has been licensed to Elder by an Israeli company Enzymotec, which specializes in de

Read More >>

February 14 ,2008 - Elder Pharmaceuticals, a Mumbai-based Rs 500 crore company has announced the launch of its new product – PHYTOMEGA a unique combination of Omega-3 fatty acids & Phytosterols which has been proven to reduce lipid levels in the body. This product has been licensed to Elder by an Israeli company – M/s

Read More >>

July 26 ,2007 - Elder Pharma to acquire 20-per cent stake in UKs Neutra Health news 26 July 2007 Mumbai: Elder Pharmaceuticals Ltd will acquire a 20 per cent strategic stake in Neutra Health PLC, an AIM-listed company in the UK. The deal involves an investment of £5.63 million pounds (Rs46-47 crore). E

Read More >>

July 26 ,2007 - Elder Pharma has bought 20-per cent stake in UK-based Neutra Health, a marketing and distribution company listed on Londons Alternative Investment Market (AIM), for Rs47 crore. (See: Elder Pharma to acquire 20-per cent stake in UKs Neutra Health) Alok Saxena, director, international, Elder Phar

Read More >>

March 14 ,2007 - Elder Pharmaceuticals has entered into an alliance with Laboratorios Farmaceuticos Rovi (ROVI) of Spain to market advanced heparins (anti-thrombotics) in India for treatment and prevention of thrombo-embolic venous diseases like deep vein thrombosis and pulmonary embolism. According to an officia

Read More >>

April 5 ,2006 - The BIRD flu virus may have created a scare and badly hit the poultry industry, but it has thrown up new opportunities for pharmaceutical companies. Elder Pharmaceuticals is launching a spray product, Trigene, to contain bird flu in poultry farms. Trigene, which is already selling in China, is manuf

Read More >>

March 5 ,2005 - Elder Pharma posts excellent results for year ended Mar 05

Read More >>